NTRA Q4 2025 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$29B

Q4 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$666M+39.8% YoY

Gross Profit

$447M67.1% margin

Operating Income

-$23M-3.4% margin

Net Income

$47M7.1% margin

EPS (Diluted)

$0.35

QoQ Revenue Growth

+12.4%

Cash Flow

Operating Cash Flow

$74M

Free Cash Flow

$38M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$686M

Stockholders' Equity

$1.7B

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$666M	$476M	+39.8%
Gross Profit	$447M	$300M	+49.1%
Operating Income	-$23M	-$65M	+64.8%
Net Income	$47M	-$54M	+187.9%

Revenue Segments

Product

$661M99%

Licensing and other

$4M1%

Geographic Segments

United States

$652M99%

Americas, excluding U.S.

$5M1%

Asia Pacific and Other

$2M0%